Skip to Main Content

Paper Details

Clonal hematopoiesis in sickle cell disease.
J Clin Invest
22
2022
CH, Clonal hematopoiesis, SCD, cancer, hydroxyurea, myeloid cancers, myeloid malignancies, myeloid malignancy, premalignant condition, sickle cell disease, whole-genome sequences
Author NameAffiliation
Yingze ZhangUniversity of Pittsburgh
Yingze ZhangUniversity of Pittsburgh
Mehdi NouraieUniversity of Pittsburgh
Mark T GladwinUniversity of Pittsburgh
Mark T GladwinUniversity of Pittsburgh
Melanie E GarrettDuke University Medical Center
Allison E Ashley-KochDuke University Medical Center
Marilyn J TelenDuke University Medical Center
Brian CusterVitalant Research Institute
Brian Custer
Carla Luana Dinardo
Carla Luana DinardoInstitute of Tropical Medicine, Faculdade de Medicina da Universidade de Sao Paulo
Paula Loureiro
Anna Bárbara de Freitas Carneiro-Proietti
Claudia Maximo
Alexander P ReinerUniversity of Washington
Alexander P ReinerFred Hutchinson Cancer Research Center
Gon??alo R AbecasisCenter for Statistical Genetics, University of Michigan School of Public Health ann arbor
Gon??alo R AbecasisCenter for Statistical Genetics, University of Michigan School of Public Health ann arbor
Pradeep NatarajanBroad Institute of MIT and Harvard
Pradeep NatarajanCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School
Alexander G BickVanderbilt University Medical Center
Vijay G SankaranBoston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Vijay G SankaranBroad Institute of MIT and Harvard
Vijay G SankaranHarvard Stem Cell Institute
  • 1 - 25

Datasets

Release 1.2